Irene
Gañan Gomez
Investigadora
University of Michigan Medical School
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan Medical School (4)
2024
-
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
Nature Communications, Vol. 15, Núm. 1
2022
-
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
Nature Medicine
-
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Nature Medicine, Vol. 28, Núm. 3, pp. 557-567
2021
-
Hematopoiesis under telomere attrition at the single-cell resolution
Nature Communications, Vol. 12, Núm. 1